Project Grant R00AA030665
Award Date 5/1/25
Completion Date 4/30/28
Dollars Obligated $498K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60608, USA
Similar Awards
- This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support a research study examining emotion regulation strategy use in an outpatient treatment program for adolescents with co-occurring alcohol use disorder (AUD) and psychiatric diagnoses. The $248,770 award, made on September 25, 2025, will fund a pilot study to test the feasibility and acceptability of an ecological momentary assessment (EMA)...
- This federal Project Grant award of $551,464 was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273). The funding will support a 5-year research project led by the Palo Alto Veterans Institute For Research (Pavir) to assess the impact of deep transcranial magnetic stimulation (DTMS) on neural targets associated with alcohol use disorder. The key objectives of the research project are to: 1) evaluate the efficacy of active...
- This Project Grant award was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), which falls under the federal Alcohol Research Programs (CFDA 93.273). The $692,723 award will support a double-blind, placebo-controlled clinical trial to test whether the drug suvorexant can be used as a novel therapeutic for alcohol use disorder (AUD) and stress-related drinking. The 5-year project, running from September 2025 through August 2030, will be conducted by researchers at The...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), awarded a $390,454 Project Grant to Envisbio LLC to develop novel therapeutic aptamers targeting phosphodiesterase 4B (PDE4B) for the treatment of alcohol use disorder (AUD). The project aims to identify and characterize PDE4B-specific aptamers that can modulate PDE4B activity, with the goal of advancing these modulators into in vivo testing and eventual human clinical trials for...
- This $166,059 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund research at Carnegie Mellon University to study the prevalence, developmental trajectories, and risk/protective factors associated with solitary alcohol use among young adults in the United States. The research aims to: 1) Estimate the prevalence of solitary alcohol use among 18-30 year olds over time, 2) Model developmental patterns of...
- This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under CFDA 93.273 - Alcohol Research Programs, will fund a longitudinal study on alcohol consumption, contexts, and consequences across the transition to legal drinking age in the United States. The University of Missouri System will receive $719,749 to conduct this 5-year study, starting on September 10, 2025. The researchers will use ecological momentary assessment (EMA) to collect self-report,...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), through its Alcohol Research Programs (CFDA 93.273), awarded a $734,468 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "SOCIAL IDENTITY MAPPING FOR ADOLESCENT RECOVERY: DEVELOPING A NOVEL SOCIAL NETWORK INTERVENTION". The goal of this 3-year project, with a period of performance from Sep 2025 to Aug 2028, is to finalize and pilot test a new...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $399,048 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the Rochester Institute of Technology (RIT) to examine behavioral and electrophysiological cue reactivity in young adult binge drinkers. The study will compare responses to uni- and multisensory alcohol and neutral cues that vary in degree of realistic appearance, and explore the effects of multisensory congruence on cue responses. The project...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $305,545 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Spark Biomedical Inc. to study the use of transcutaneous auricular neurostimulation (TAN) as a treatment for alcohol use disorder. The research aims to investigate the efficacy of TAN in reducing alcohol withdrawal symptoms and developing neuroimaging biomarkers for alcohol use disorder. Spark Biomedical, a small disadvantaged business...
- This Project Grant award, totaling $560,108.00 and spanning September 15, 2025 to August 31, 2030, was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The purpose of the project is to investigate the neurocognitive mechanisms that promote resilience to alcohol use disorder (AUD) in individuals with a family history of AUD. Specifically, the research will examine how attentional abilities may...